A brief history of TRIM5α

AIDS Reviews

Volumn 9, Issue 2, 2007, Pages 114-125

  Newman, Ruchi M ^a   Johnson, Welkin E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Restriction factor; Retrovirus; TRIM; TRIM5 ; Tripartite motif

Indexed keywords

CYCLOPHILIN A; GAG PROTEIN; POL PROTEIN; REDOX EFFECTOR FACTOR 1; TRIPARTITE MOTIF PROTEIN 5; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; CARRIER PROTEIN; PROTEIN; TRIM5 PROTEIN, HUMAN; TRIM5(ALPHA) PROTEIN, RHESUS MONKEY; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; EPIDEMIC; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; MURINE LEUKEMIA VIRUS; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS RESISTANCE; ANIMAL; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PRIMATE; VIROLOGY;

ANIMALS; CARRIER PROTEINS; HIV INFECTIONS; HIV-1; HUMANS; PRIMATES; PROTEINS;

EID: 34547475019     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Agy M, Frumkin L, Corey L, et al. Infection of Macaca nemestrina by HIV-1. Science 1992;257:103-6.
2. Agy M, Schmidt A, Florey M, et al. Serial in vivo passage of HIV-1 infection in Macaca nemestrina. Virology 1997;238:336-43.
3. Alter H, Eichberg J, Masur H, et al. Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science 1984;226:549-52.
4. Anderson J, Campbell E, Wu X, Vandegraaff N, Engelman A, Hope T. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. J Virol 2006;80:9754-60.
5. Besnier C, Takeuchi Y, Towers G. Restriction of lentivirus in mon-keys. Proc Natl Acad Sci USA 2002;99:11920-5.
6. Besnier C, Ylinen L, Strange B, et al. Characterization of murine leukemia virus restriction in mammals. J Virol 2003;77:13403-6.
7. Bieniasz P. Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 2004;5:1109-15.
8. Bieniasz P. Restriction factors: a defense against retroviral infection. Trends Microbiol 2003;11:286-91.
9. Borden K, Lally J, Martin S, O'Reilly N, Etkin L, Freemont P. Novel topology of a zinc-binding domain from a protein involved in regulating early Xenopus development. Embo J 1995;14:5947-56.
10. Braaten D, Aberham C, Franke E, Yin L, Phares W, Luban J. Cyclosporine A-resistant HIV-1 mutants demonstrate that Gag encodes the functional target of cyclophilin A. J Virol 1996;70:5170-6.
11. Braaten D, Franke E, Luban J. Cyclophilin A is required for an early step in the life cycle of HIV-1 before the initiation of reverse transcription. J Virol 1996;70:3551-60.
12. Braaten D, Luban J. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. Embo J 2001;20:1300-9.
13. Bukovsky A, Weimann A, Accola M, Gottlinger H. Transfer of the HIV-1 cyclophilin-binding site to SIV from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence. Proc Natl Acad Sci USA 1997;94:10943-8.
14. Chatterji U, Bobardt M, Gaskill P, Sheeter D, Fox H, Gallay P. Trim5 accelerates degradation of cytosolic capsid associated with productive HIV-1 entry. J Biol Chem 2006;281:37025-33.
15. Cowan S, Hatziioannou T, Cunningham T, Muesing M, Gottlinger H, Bieniasz P. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc Natl Acad Sci USA 2002;99:11914-9.
16. d'Azzo A, Bongiovanni A, Nastasi T. E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation. Traffic 2005;6:429-41.
17. Daniel M, Letvin N, King N, et al. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 1985;228:1201-4.
18. Diaz-Griffero F, Li X, Javanbakht H, et al. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 2006;349:300-15.
19. Dorfman T, Gottlinger H. The HIV-1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. J Virol 1996;70:5751-7.
20. Dorfman T, Weimann A, Borsetti A, Walsh C, Gottlinger H. Active-site residues of cyclophilin A are crucial for its incorporation into HIV-1 virions. J Virol 1997;71:7110-3.
21. Emerman M. How TRIM5α defends against retroviral invasions. Proc Natl Acad Sci USA 2006;103:5249-50.
22. Franke E, Luban J. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 1996;222:279-82.
23. Franke E, Yuan H, Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994;372:359-62.
24. Fultz P, McClure H, Daugharty H, et al. Vaginal transmission of HIV to a chimpanzee. J Infect Dis 1986;154:896-900.
25. Gajdusek D, Amyx H, Gibbs Jr. C, et al. Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients. Lancet 1985;1:55-6.
26. Gardner M. Simian AIDS: an historical perspective. J Med Primatol 2003;32:180-6.
27. Gardner M, Luciw P. Animal models of AIDS. Faseb J 1989;3: 2593-606.
28. Gartner S, Liu Y, Lewis M, et al. HIV-1 infection in pigtailed macaques. AIDS Res Hum Retroviruses 1994;10(Suppl 2):S129-33.
29. Gifford R, Tristem M. The evolution, distribution and diversity of endogenous retroviruses. Virus Genes 2003;26:291-315.
30. Goff S. Genetic control of retrovirus susceptibility in mammalian cells. Annu Rev Genet 2004;38:61-85.
31. Goff S. Retrovirus restriction factors. Mol Cell 2004;16:849-59.
32. Goldschmidt V, Bleiber G, May M, Martinez R, Ortiz M, Telenti A. Role of common human TRIM5α variants in HIV-1 disease progression. Retrovirology 2006;3:54.
33. Grutter C, Briand C, Capitani G, et al. Structure of the PRYSPRY-domain: implications for autoinflammatory diseases. FEBS Lett 2006;580:99-106.
34. Guo Z, Zhou D, Schultz P. Designing small-molecule switches for protein-protein interactions. Science 2003;288:2042-5.
35. Hall L, Newman R, Pery E, Farzan M, Johnson W. 2007 [unpublished observations].
36. Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz P. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5α. Proc Natl Acad Sci USA 2004; 101:10774-9.
37. Hatziioannou T, Princiotta M, Piatak Jr. M, et al. Generation of simiantropic HIV-1 by restriction factor evasion. Science 2006;314:95.
38. Himathongkham S, Luciw P. Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 1996;219:485-8.
39. Hofmann W, Schubert D, LaBonte J, et al. Species-specific, postentry barriers to primate immunodeficiency virus infection. J Virol 1999;73:10020-8.
40. Hughes A, Nei M. Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 1988;335:167-70.
41. Hughes A, Yeager M. Natural selection at major histocompatibility complex loci of vertebrates. Annu Rev Genet 1998;32:415-35.
42. Ikeda Y, Collins M, Radcliffe P, Mitrophanous K, Takeuchi Y. Gene transduction efficiency in cells of different species by HIV and EIAV vectors. Gene Ther 2002;9:932-8.
43. Javanbakht H, An P, Gold B, el al. Effects of human TRIM5α polymorphisms on antiretroviral function and susceptibility to HIV infection. Virology 2006;354:15-27.
44. Javanbakht H, Diaz-Griffero F, Stremlau M, Si Z, Sodroski J. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5α. J Biol Chem 2005;280:26933-40.
45. Javanbakht H, Yuan W, Yeung D, et al. Characterization of TRIM5α trimerization and its contribution to HIV capsid binding. Virology 2006;353:234-46.
46. Kamada K, Igarashi T, Martin M, et al. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc Natl Acad Sci USA 2006;103:16959-64.
47. Keckesova Z, Ylinen L, Towers G. The human and African green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci USA 2004101:10780-5.
48. Kent S, Corey L, Agy M, Morton W, McElrath M, Greenberg P. Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina. J Clin Invest 1995;95:248-56.
49. Kimball L, Bosch M. In vitro HIV-1 infection in Macaca nemestrina PBMCs is blocked at a step beyond reverse transcription. J Med Primatol 1998;27:99-103.
50. Lee Y, Bieniasz P. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog 2007;3:e10.
51. Li J, Lord C, Haseltine W, Letvin N, Sodroski J. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J Acquir Immune Defic Syndr 1992;5:639-46.
52. Li S, Hill C, Sundquist W, Finch J. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 2003;407:409-13.
53. Li X, Gold B, O'Huigin C, et al. Unique features of TRIM5α among closely related human TRIM family members. Virology 2007;360: 419-33.
54. Li X, Li Y, Stremlau M, et al. Functional replacement of the RING, B-Box 2, and coiled-coil domains of tripartite motif 5α (TRIM5α) by heterologous TRIM domains. J Virol 2006;80:6198-206.
55. Li Y, Li X, Stremlau M, Lee M, Sodroski J. Removal of arginine 332 allows human TRIM5alpha to bind HIV capsids and to restrict infection. J Virol 2006;80:6738-44.
56. Liu H, Wang Y, Liao C, Kuang Y, Zheng Y, Su B. Adaptive evolution of primate TRIM5α, a gene restricting HIV-1 infection. Gene 2005;362:109-16.
57. Luban J. Cyclophilin A, TRIMS, and resistance to HIV-1 infection. J Virol 2007;81:1054-61.
58. Luban J, Bossolt K, Franke E, Kalpana G, Goff S. HIV-1 Gag protein binds to cyclophilins A and B. Cell 1993;73:1067-78.
59. Lusso P, Markham P, Ranki A, et al. Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with HIV-1. J Immunol 1988;141:2467-73.
60. Masters S, Yao S, Willson T, et al. The SPRY domain of SSB-2 adopts a novel fold that presents conserved Par-4-binding residues. Nat Struct Mol Biol 2006;13:77-84.
61. Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 2005;27:1147-57.
62. Mische C, Javanbakht H, Song B, et al. Retroviral restriction factor TRIM5α is a trimer. J Virol 2005;79:14446-50.
63. Munk C, Brandt S, Lucero G, Landau N. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc Natl Acad Sci USA 2002;99:13843-8.
64. Nakayama E, Miyoshi H, Nagai Y, Shioda T. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5α determines species-specific restriction of SIVmac infection. J Virol 2005;79:8870-7.
65. Newman R, Hall L, Connole M, et al. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5α. Proc Natl Acad Sci USA 2006;103:19134-9.
66. Nisole S, Lynch C, Stoye J, Yap M. A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc Natl Acad Sci USA 2004;101:13324-8.
67. Nisole S, Stoye J, Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 2005;3:799-808.
68. Ohkura S, Yap M, Sheldon T, Stoye J. All three variable regions of the TRIM5α B30.2 domain can contribute to the specificity of retrovirus restriction. J Virol 2006;80:8554-66.
69. Ortiz M, Bleiber G, Martinez R, Kaessmann H, Telenti A. Patterns of evolution of host proteins involved in retroviral pathogenesis. Retrovirology 2006;3:11.
70. Otten R, Brown B, Simon M, et al. Differential replication and pathogenic effects of HIV-1 and HIV-2 in Macaca nemestrina. Aids 1994;8:297-306.
71. Owens C, Song B, Perron M, Yang P, Stremlau M, Sodroski J. Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the HIV-1 capsid. J Virol 2004;78:5423-37.
72. Perez-Caballero D, Hatziioannou T, Yang A, Cowan S, Bieniasz P. Human tripartite motif 5α domains responsible for retrovirus restriction activity and specificity. J Virol 2005;79:8969-78.
73. Perez-Caballero D, Hatziioannou T, Zhang F, Cowan S, Bieniasz P. Restriction of HIV-1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity. J Virol 2005;79:15567-72.
74. Perron M, Stremlau M, Lee M, Javanbakht H, Song B, Sodroski J. The human TRIM5α restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid. J Virol 2007;81:2138-48.
75. Perron M, Stremlau M, Sodroski J. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5α. J Virol 2006;80:5631-6.
76. Perron M, Stremlau M, Song B, Ulm W, Mulligan R, Sodroski J. TRIM5α mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc Natl Acad Sci USA 2004;101: 11827-32.
77. Reymond A, Meroni G, Fantozzi A, et al. The tripartite motif family identifies cell compartments. Embo J 2001;20:2140-51.
78. Ribeiro I, Menezes A, Moreira M, Bonvicino C, Seuanez H, Soares M. Evolution of cyclophilin A and TRIMCyp retrotransposition in New World primates. J Virol 2005;79:14996-5003.
79. Saenz D, Teo W, Olsen J, Poeschla E. Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5α proteins. J Virol 2005;79:15175-88.
80. Sawyer S, Wu L, Akey J, Emerman M, Malik H. High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5α in humans. Curr Biol 2006;16:95-100.
81. Sawyer S, Wu L, Emerman M, Malik H. Positive selection of primate TRIM5α identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci USA 2005;102:2832-7.
82. Sayah D, Sokolskaja E, Berthoux L, Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004;430:569-73.
83. Sebastian S, Luban J. TRIM5α selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2005;2:40.
84. Shibata R, Adachi A. SIV/HIV recombinants and their use in studying biological properties. AIDS Res Hum Retroviruses 1992; 8:403-9.
85. Shibata R, Kawamura M, Sakai H, Hayami M, Ishimoto A, Adachi A. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J Virol 1991;65:3514-20.
86. Shibata R, Sakai H, Kawamura M, Tokunaga K, Adachi A. Early replication block of HIV-1 in monkey cells. J Gen Virol 1995;76:2723-30.
87. Shoham N, Cohen L, Gazit A, Yaniv A. The Tat protein of the caprine arthritis encephalitis virus interacts with the Notch2 EGF-like repeats and the epithelin/granulin precursor. Intervirology 2003;46:239-44.
88. Short K, Hopwood B, Yi Z, Cox T. MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders. BMC Cell Biol 2002;3:1.
89. Si Z, Vandegraaff N, O'Huigin C, et al. Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proc Natl Acad Sci USA 2006;103:7454-9.
90. Sokolskaja E, Luban J. Cyclophilin, TRIMS, and innate immunity to HIV-1. Curr Opin Microbiol 2006;9:404-8.
91. Song B, Diaz-Griffero F, Park do H, Rogers T, Stremlau M, Sodroski J. TRIM5α association with cytoplasmic bodies is not required for antiretroviral activity. Virology 2005;343:201-11.
92. Song B, Gold B, O'Huigin C, et al. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5α exhibits lineage-specific length and sequence variation in primates. J Virol 2005;79:6111-21.
93. Song B, Javanbakht H, Perron M, Park D, Stremlau M, Sodroski J. Retrovirus restriction by TRIM5α variants from Old World and New World primates. J Virol 2005;79:3930-7.
94. Speelmon E, Livingston-Rosanoff D, Li S, et al. Genetic association of the antiviral restriction factor TRIM5α with HIV-1 infection. J Virol 2006;80:2463-71.
95. Storey J, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003;100:9440-5.
96. Stremlau M, Owens C, Perron M, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5α, restricts HIV-1 infection in Old World monkeys. Nature 2004;427:848-53.
97. Stremlau M, Perron M, Lee M, et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5α restriction factor. Proc Natl Acad Sci USA 2006;103:5514-9.
98. Stremlau M, Perron M, Welikala S, Sodroski J. Species-specific variation in the B30.2(SPRY) domain of TRIM5α determines the potency of HIV restriction. J Virol 2005;79:3139-46.
99. Thali M, Bukovsky A, Kondo E, et al. Functional association of cyclophilin A with HIV-1 virions. Nature 1994;372:363-5.
100. Torok M, Etkin L. Two B or not two B? Overview of the rapidly expanding B-box family of proteins. Differentiation 2001;67:63-71.
101. Towers G, Bock M, Martin S, Takeuchi Y, Stoye J, Danos O. A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci USA 2000;97:12295-9.
102. Towers G, Hatziioannou T, Cowan S, Goff S, Luban J, Bieniasz P. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med 2003;9:1138-43.
103. Woo J, Imm J, Min C, Kim K, Cha S, Oh B. Structural and functional insights into the B30.2/SPRY domain. Embo J 2006; 25:1353-63.
104. Wu X, Anderson J, Campbell E, Joseph A, Hope T. Proteasome inhibitors uncouple rhesus TRIM5α restriction of HIV-1 reverse transcription and infection. Proc Natl Acad Sci USA 2006;103: 7465-70.
105. Xing J, Wang H, Belancio V, Cordaux R, Deininger P, Batzer M. Emergence of primate genes by retrotransposon-mediated sequence transduction. Proc Natl Acad Sci USA 2006;103: 17608-13.
106. Xu L, Yang L, Moitra P, et al. BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta. Exp Cell Res 2003;288:84-93.
107. Yang Z. The power of phylogenetic comparison in revealing protein function. Proc Natl Acad Sci USA 2005;102:3179-80.
108. Yao S, Liu M, Masters S, et al. Dynamics of the SPRY domain-containing SOCS box protein 2: flexibility of key functional loops. Protein Sci 2006;15:2761-72.
109. Yap M, Nisole S, Lynch C, Stoye J. Trim5α protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci USA 2004; 101:10786-91.
110. Yap M, Nisole S, Stoye J. A single amino acid change in the SPRY domain of human Trim5α leads to HIV-1 restriction. Curr Biol 2005; 15:73-8.
111. Ylinen L, Keckesova Z, Webb B, Gifford R, Smith T, Towers G. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals. J Virol 2006;80:7332-8.